D.L.S.I. Logo

D.L.S.I.

HR and recruitment services for temp, fixed-term, and permanent roles across industries.

ALDLS | PA

Overview

Corporate Details

ISIN(s):
FR0010404368
LEI:
969500EJ1VXQBOHQR803
Country:
France
Address:
Avenue Eric Bousch, 57600 Forbach
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Groupe DLSI is a human resources and recruitment services company specializing in temporary staffing, fixed-term contracts (CDD), and permanent placements (CDI). The group operates through a network of approximately 70 employment agencies and several specialized brands, including DLSI Emploi, TERCIO-RH for the tertiary sector, and EMO DLSI for wood industry trades. It serves a diverse range of industries by providing recruitment solutions for businesses and career support for job seekers across technical, administrative, and industrial roles. The company's key metrics for 2023 included 220 permanent employees and revenue of €204.5 million.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-24 17:45
Earnings Release
Groupe DLSI - Chiffre d'affaires 3ème trimestre 2025
French 259.7 KB
2025-09-26 17:45
Earnings Release
Groupe DLSI - Résultat 1er semestre 2025
French 321.6 KB
2025-06-20 11:00
Notice of Dividend Amount
Groupe DLSI - Mise en paiement du dividende 2025
French 189.0 KB
2025-05-14 10:55
Pre-Annual General Meeting Information
Groupe DLSI - Avis réunion valant convocation AGO 19-06-2025
French 496.6 KB
2025-05-12 08:50
Pre-Annual General Meeting Information
Groupe DLSI - Avis réunion valant convocation AGO 19-06-2025
French 496.6 KB
2025-05-02 15:20
Capital/Financing Update
Groupe DLSI - Transfert contrat de liquidité auprès de PORTZAMPARC BNP PARIBAS …
French 301.5 KB
2025-04-28 11:30
Audit Report / Information
Groupe DLSI - Rapport sur les comptes consolidés 2024
French 1.1 MB
2025-04-28 11:30
Related Party Transaction
Groupe DLSI - Rapport spécial sur les conventions réglementées 2024
French 440.4 KB
2025-04-26 07:00
Earnings Release
Groupe DLSI - Chiffre d'affaires 1er trimestre 2025
French 285.8 KB
2025-04-25 17:45
Earnings Release
GROUPE DLSI - Chiffre d'affaires 1er trimestre 2025
French 285.8 KB
2025-03-28 07:00
Earnings Release
Groupe DLSI - Résultat 2024
French 292.9 KB
2025-03-27 17:45
Earnings Release
Groupe DLSI - Résultat 2024
French 292.9 KB
2025-02-15 07:00
Earnings Release
Groupe DLSI - Chiffre d'affaires 2024
French 288.3 KB
2025-02-14 17:45
Earnings Release
Groupe DLSI - Chiffre d'Affaires 2024
French 288.3 KB
2025-01-25 07:00
Board/Management Information
Groupe DLSI - Nouvelle composition du Conseil de Surveillance
French 290.1 KB

Automate Your Workflow. Get a real-time feed of all D.L.S.I. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for D.L.S.I.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for D.L.S.I. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Developing novel cancer immunotherapies, including peptide vaccines and iPS-NKT cell therapies.
Japan 4594
Brilliant Future AB Logo
A data-driven survey platform to measure and improve employee & customer experiences.
Sweden BRILL
b-style holdings,Inc. Logo
Offers flexible staffing for homemakers and specialized recruitment for skilled professionals.
Japan 302A
BTS Group Logo
Helps organizations execute strategy via experiential learning for leadership and sales teams.
Sweden BTS
B.U Technology Logo
Commercializes university research via IP management, licensing, and new venture creation.
South Korea 230980
Advancing high-grade copper and precious metal projects from discovery to production.
Canada N/A
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland CTX
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan 6070
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan 4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.